Sugi Predict

Sugi Predict / Compounds / SCHEMBL2230678

SCHEMBL2230678

SCHEMBL2230678

CC(=O)c1ccc(-c2cc(C(C)(C)C)nc3[nH]nc(N)c23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.42
▸ ABL1 P00519 9/20 0.40
▸ BCR P11274 9/20 0.40
▸ PRKAB2 O43741 1/20 0.40
▸ PRKAG1 P54619 1/20 0.40
▸ PRKAA2 P54646 1/20 0.40
▸ PRKAA1 Q13131 1/20 0.40
▸ PRKAG3 Q9UGI9 1/20 0.40
▸ PRKAG2 Q9UGJ0 1/20 0.40
▸ PRKAB1 Q9Y478 1/20 0.40
▸ BTK Q06187 4/20 0.38
▸ KIT P10721 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ ADORA3 P0DMS8 2/20 0.37
▸ LTK P29376 1/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ MAP2K1 Q02750 1/20 0.37
▸ ROCK1 Q13464 1/20 0.37
▸ NTRK3 Q16288 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2821053 0.91 LTK (0.46) JAK2ABL1BCRBTKKIT
SCHEMBL2231538 0.87 DHFR (0.43) KDRLTKCDK8ROCK1
SCHEMBL2821058 0.85 KDR (0.44) JAK2ABL1BCRKITKDR
SCHEMBL2228840 0.85 KDR (0.42) JAK2ABL1BCRKITKDR
SCHEMBL2815922 0.84 KDR (0.49) JAK2ABL1BCRBTKKIT
SCHEMBL2817289 0.82 KDR (0.60) JAK2ABL1PRKAA1KITKDR
SCHEMBL14367013 0.82 KDR (0.52) JAK2ABL1KITKDRFLT3
SCHEMBL2819284 0.81 KDR (0.58) JAK2ABL1PRKAA1KITKDR
SCHEMBL2821071 0.80 KDR (0.54) JAK2ABL1PRKAA1KITKDR
SCHEMBL2822262 0.80 KDR (0.58) JAK2ABL1KITKDRFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents MAP4K2, ABL1, MAP4K3 JAK2 24/4885ABL1 2/4885BCR 832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.